TGFB1 and neoplasm: TAMs polarized to the M2 phenotype release TGF-β and VEGF, thereby suppressing antitumor immunity, whereas tumor cells produce immunosuppressive molecules such as PD-L1 to deactivate T cells and facilitate immune escape (109).